Albarrán, V.; Villamayor, M.L.; Chamorro, J.; Rosero, D.I.; Pozas, J.; San Román, M.; Calvo, J.C.; Pérez de Aguado, P.; Moreno, J.; Guerrero, P.;
et al. Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas. Int. J. Mol. Sci. 2022, 23, 13784.
https://doi.org/10.3390/ijms232213784
AMA Style
Albarrán V, Villamayor ML, Chamorro J, Rosero DI, Pozas J, San Román M, Calvo JC, Pérez de Aguado P, Moreno J, Guerrero P,
et al. Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas. International Journal of Molecular Sciences. 2022; 23(22):13784.
https://doi.org/10.3390/ijms232213784
Chicago/Turabian Style
Albarrán, Víctor, María Luisa Villamayor, Jesús Chamorro, Diana Isabel Rosero, Javier Pozas, María San Román, Juan Carlos Calvo, Patricia Pérez de Aguado, Jaime Moreno, Patricia Guerrero,
and et al. 2022. "Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas" International Journal of Molecular Sciences 23, no. 22: 13784.
https://doi.org/10.3390/ijms232213784
APA Style
Albarrán, V., Villamayor, M. L., Chamorro, J., Rosero, D. I., Pozas, J., San Román, M., Calvo, J. C., Pérez de Aguado, P., Moreno, J., Guerrero, P., González, C., García de Quevedo, C., Álvarez-Ballesteros, P., & Vaz, M. Á.
(2022). Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas. International Journal of Molecular Sciences, 23(22), 13784.
https://doi.org/10.3390/ijms232213784
